Stock market news live updates: Stocks sink, tech lags after Walmart profit warning – Yahoo Finance

U.S. stocks tumbled on Tuesday after Walmart’s (WMT) profit warning Monday night and ahead of a rush of tech earnings and the Fed’s latest policy statement on Wednesday.
At the closing bell, the benchmark S&P 500 lost 1.2%, while the Dow fell some 0.7%.
The tech-heavy Nasdaq fell 1.9%, the index’s third-straight losing session and the third-straight day losses for the Nasdaq have outpaced those suffered by the S&P and Dow.
Shares of Walmart (WMT) fell over 7% after the retail giant slashed its second quarter and full-year profit outlooks late Monday, citing rampant inflation and a resulting pullback in consumer spending on discretionary items.
“The increasing levels of food and fuel inflation are affecting how customers spend, and while we’ve made good progress clearing hardline categories, apparel in Walmart U.S. is requiring more markdown dollars,” Walmart CEO Doug McMillon in a statement. “We’re now anticipating more pressure on general merchandise in the back half; however, we’re encouraged by the start we’re seeing on school supplies in Walmart U.S.”
Walmart’s warning sent dragged down other retailers. Amazon (AMZN), Target (TGT), and Dollar General (DG) each fell as much as 5%, 4%, and 3%, respectively.
Shopify’s (SHOP) stock nosedived nearly 16% after the e-commerce giant said it was laying off roughly 10% of its global workforce after a hiring boom to meet pandemic demand for online shopping.
“It’s now clear that bet didn’t pay off,” CEO Tobi Lutke said in a statement. “What we see now is the mix reverting to roughly where pre-Covid data would have suggested it should be at this point.”
Also weighing on sentiment was a disappointing report from General Motors (GM) early Tuesday that showed second-quarter results fell short of Wall Street estimates. The Detroit-based automaker saw its net income fall 40% from a year ago during the period and said it failed to deliver 95,000 vehicles due to part shortages. Shares fell nearly as much as 3%.
Elsewhere in markets, UBS (UBS) shares fell as much as 12% after the Swiss bank reported a smaller quarterly profit than analyst anticipated as market volatility weighed on investment banking revenues and the financial institution warned of a challenging second half of the year.
In economic news, the International Monetary Fund further downgraded its forecast for global growth this year and warned of a “gloomy and more uncertain” amid worse-than-expected inflation. The organization now projects the global economy will grow by only 3.2% this year, a downgrade from the 3.6% it had previously forecast in April when it cut expectations for 2022 to 3.6% from 4.4%.
Federal Reserve officials also kicked off their two-day policy meeting Tuesday and are expected to raise interest rates another 75 basis points at its conclusion Wednesday afternoon.
Federal Reserve Chair Jerome Powell is set to deliver remarks at 2:30 p.m. ET shortly after the U.S. central bank’s policy decision comes out at 2:00 p.m. ET.

Alexandra Semenova is a reporter for Yahoo Finance. Follow her on Twitter @alexandraandnyc
Click here for the latest stock market news and in-depth analysis, including events that move stocks
Read the latest financial and business news from Yahoo Finance
Download the Yahoo Finance app for Apple or Android
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube
Related Quotes
Yahoo Finance Live anchors discuss reports that Apple has ditched plans to increase iPhone 14 production.
Shares of Biogen (NASDAQ: BIIB) were skyrocketing 36% as of 11:10 a.m. ET on Wednesday. The huge gain came after the company and its partner Eisai (OTC: ESALY) announced positive results on Tuesday from their late-stage Clarity AD study evaluating lecanemab in treating Alzheimer's disease. The news also propelled two stocks of other drugmakers developing Alzheimer's disease drugs significantly higher.
Yahoo Finance's Allie Garfinkle discusses news that Apple has asked suppliers to pull back production by up to 6 million units and what it signals about consumer demand ahead of the holiday season.
Yahoo Finance Live anchors discuss Biogen stock performance on promising Alzheimer’s drug trial data.
Boyar Research's Jonathan Boyar joins Yahoo Finance Live to discuss low stock valuations, the stock market, and his stock picks in the financial and tech sectors.
In this article, we will be taking a look at the 10 companies that are buying back their stock in 2022. To skip our detailed analysis of these companies, you can go directly to see the 5 Companies that are Buying Back Their Stock in 2022. So far in 2022, we have seen a number of […]
General Motors CEO Mary Barra yesterday apologized to salaried workers for the timing of a memo sent late Friday afternoon outlining a new back-to-office policy and delayed the implementation of the plan. The email said that GM employees who had been working remotely during the pandemic would be required later this year to return to the office at least three days a week, the Detroit Free Press reported. The email triggered employee pushback about both the updated policy and the timing of the announcement, leading Barra to partially walk back the decision, announcing Tuesday that the automaker will not implement the requirement this year but that “a more regular, in-person presence” will still be the plan for the future.
The benchmark S&P 500, which is typically viewed as the best barometer of stock market health, produced its worst first-half return in 52 years. As for the growth-driven Nasdaq Composite, an index largely responsible for pushing the stock market to new highs, it's lost about a third of its value. This puts both the S&P 500 and Nasdaq firmly in a bear market.
Mind Medicine (MindMed) Inc. ("MindMed") (NASDAQ: MNMD) (NEO: MMED), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced the pricing of its underwritten public offering of 7,058,823 common shares, together with accompanying warrants to purchase 7,058,823 common shares. The combined offering price to the public of each common share and accompanying warrant is $4.25. Each common share will be sold in combination with an accompanying
In this article, we will discuss the 10 dividend paying stocks you should avoid according to Morgan Stanley’s quant screen. If you want to read about similar stocks, you can also take a look at 5 Dividend Paying Stocks You Should Avoid According to Morgan Stanley’s Quant Screen. Morgan Stanley’s Sherry Paul: “It’s a Buying […]
Palantir's stock is down 58% year to date, but its latest results may shed some light on why now could be a generational buying opportunity.
Biogen stock rips higher on a promising new drug. Here's what Wall Street is saying.
Lockheed Martin (LMT) closed the most recent trading day at $399.74, moving -1.94% from the previous trading session.
My children have inherited $5 million of stock from their father (whose estate has not yet been dispersed after 11 months) leaving them with a 30% or so loss of value over which they have had no control. Is there … Continue reading → The post Ask an Advisor: My Kids Inherited $5 Million. How Should They Handle It? appeared first on SmartAsset Blog.
Atlantic Equities analyst Hamilton Faber upgraded Netflix stock to overweight (buy) from neutral (hold), while simultaneously boosting his price target to $283, up from its former level of $211. The analyst cited the debut of Netflix's upcoming ad-supported tier, which he believes "could be extremely material" for the streaming service, the benefits of which haven't yet been accurately reflected in analysts' consensus estimates. Faber estimates that Netflix could generate average revenue per user (ARPU) of $26 per month from advertising, more than three times the rate of Disney's Hulu.
In this article, we will discuss the 10 dividend paying stocks to buy according to Morgan Stanley’s quant screen. If you want to explore similar stocks, you can also take a look at 5 Best Dividend Stocks to Buy According to Morgan Stanley’s Quant Screen. Morgan Stanley’s Base Case: S&P Falling to $3,400 by Year […]
Biogen stock catapulted Wednesday — bringing shares of other Alzheimer's plays with it — after its experimental treatment succeeded in a test.
For many retail investors, the events of late January 2021 will go down in legend. The year 2020 could be characterized as the rise of the retail investor. Amid the retail revolution, one voice rose to the top.
Yahoo Finance Live anchors discuss VF Corp. slashing its full-year outlook on weak demand.
Anyone following stock market trends in 2022 will be well aware of the widespread drawbacks; apart from some outliers such as energy, most corners of the market have been beaten to a pulp. The main culprits are easily identified by now; a combination of a slowing economy, rampant inflation, rates hikes to halt it, and Russia’s invasion of Ukraine and the global implications are all responsible factors. Stock market giants have not been immune either and many have seen huge chunks of their valuat

source

Leave a Comment